These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Marrow transplantation from unrelated volunteer donors. Anasetti C; Etzioni R; Petersdorf EW; Martin PJ; Hansen JA Annu Rev Med; 1995; 46():169-79. PubMed ID: 7598453 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation in the treatment of hematologic diseases. Yee GC; McGuire TR Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273 [TBL] [Abstract][Full Text] [Related]
7. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093 [TBL] [Abstract][Full Text] [Related]
8. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923 [TBL] [Abstract][Full Text] [Related]
9. Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors. Hasegawa W; Lipton JH; Messner HA; Jamal H; Yi QL; Daly AS; Kotchetkova N; Kiss TL Hematology; 2003 Feb; 8(1):27-33. PubMed ID: 12623424 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Chim CS; Lie AK; Liang R; Au WY; Kwong YL Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712 [TBL] [Abstract][Full Text] [Related]
12. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644 [TBL] [Abstract][Full Text] [Related]
13. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings]. Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395 [TBL] [Abstract][Full Text] [Related]
14. [Mini-transplantation from HLA-mismatched donors]. Ogawa H Nihon Rinsho; 2003 Sep; 61(9):1549-54. PubMed ID: 14515722 [TBL] [Abstract][Full Text] [Related]
15. [Indications, problems and future perspectives of bone marrow transplantation in pediatrics]. Slavc I Padiatr Padol; 1992; 27(6):167-75. PubMed ID: 1484709 [TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation: procedures and complications. Parr MD; Messino MJ; McIntyre W Am J Hosp Pharm; 1991 Jan; 48(1):127-37. PubMed ID: 2000873 [TBL] [Abstract][Full Text] [Related]